We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$959M
AUM Growth
+$89.9M
Cap. Flow
+$164M
Cap. Flow %
17.13%
Top 10 Hldgs %
50.75%
Holding
107
New
30
Increased
18
Reduced
14
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 20.26%
2 Industrials 8.56%
3 Consumer Discretionary 7.01%
4 Materials 6.46%
5 Financials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANW icon
101
PUT
Palo Alto Networks
PANW
$297B
-88,200
Closed -$8.18M
RAPT
102
CALL
DELISTED
RAPT Therapeutics
RAPT
-12,500
Closed -$3.67M
RNR icon
103
RenaissanceRe
RNR
$13.4B
-175,000
Closed -$29.6M
UAA icon
104
Under Armour
UAA
$2.6B
-697,000
Closed -$14.8M
VRTX icon
105
Vertex Pharmaceuticals
VRTX
$126B
-77,300
Closed -$17M
DCPH
106
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-150,000
Closed -$1.47M
ARNA
107
DELISTED
Arena Pharmaceuticals Inc
ARNA
-55,555
Closed -$5.16M

Similar funds

Kingdon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Kingdon Capital Management held 107 positions worth $959M, up 10% from $870M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kingdon Capital Management deployed $164M of net new capital in Q1 2022, opening 30 new positions and adding to 18 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20.5M trimmed.

  • Kingdon Capital Management's largest Q1 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.
  • Kingdon Capital Management added most to Amazon in Q1 2022, an estimated $15.3M increase.
  • Kingdon Capital Management's biggest Q1 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.5M.
  • Kingdon Capital Management fully exited RenaissanceRe in Q1 2022, selling an estimated $29.6M.
  • Kingdon Capital Management's ten largest holdings make up 51% of its $959M portfolio in Q1 2022.
  • Kingdon Capital Management opened 30 new positions and closed 25 in Q1 2022.
  • Kingdon Capital Management's portfolio value rose 10% quarter-over-quarter to $959M.

Based on Kingdon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.